Загрузка...
Adding ezetimibe to statin therapy: latest evidence and clinical implications
BACKGROUND: Statins are the hypolipemic treatment of choice for hyperlipidemia with confirmed atherosclerotic cardiovascular disease (ASCVD) protective effect, proven even in normolipemic patients. But in rare situations, even with a high-dose treatment regimen, or maximally tolerated statin dose tr...
Сохранить в:
| Опубликовано в: : | Drugs Context |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioExcel Publishing Ltd
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6044319/ https://ncbi.nlm.nih.gov/pubmed/30023003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212534 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|